CM-118

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameCM-118
Drug Alias NameCM-118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitorsAnaplastic lymphoma kinase inhibitors
TargetsAnaplastic lymphoma kinaseHepatocyte growth factor receptor
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesXcovery
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen Nanfang Ying Shun Pharmacuetic Ltd
Inactive CompaniesShanghai Zaixin Pharmaceutical Technology Co Ltd
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A